BIOTRICITY INC (BTCY) Stock Analyst Earnings Estimates
NASDAQ:BTCY - Nasdaq - US09074H2031 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 7.65M 126.33% | 9.64M 26.01% | 12.063M 25.14% | 14.586M 20.91% | |
| EBITDA YoY % growth | -17.47M | -13.61M 22.10% | -5.804M 57.36% | N/A | |
| EBIT YoY % growth | -17.47M -35.74% | -13.62M 22.04% | -5.809M 57.35% | -8.466M -45.73% | |
| Operating Margin | -228.37% | -141.29% | -48.16% | -58.04% | |
| EPS YoY % growth | -1.61 | -2.24 -39.38% | -1.66 26.07% | -0.44 73.56% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.47 13.15% | -0.37 | -0.10 | -27.72% |
| Q3 2024 Q2Q % growth | -0.34 37.22% | -0.45 | 0.11 | 24.47% |
| Q2 2024 Q2Q % growth | -0.44 21.81% | -0.35 | -0.09 | -27.16% |
| Q1 2024 Q2Q % growth | -0.41 31.67% | -0.42 | 0.01 | 1.96% |
| Q4 2023 Q2Q % growth | -0.54 18.18% | -0.55 | 0.01 | 1.96% |
| Q3 2023 Q2Q % growth | -0.54 25.00% | -0.55 | 0.01 | 1.96% |
| Q2 2023 Q2Q % growth | -0.56 -302.86% | -0.45 | -0.12 | -25.67% |
| Q1 2023 Q2Q % growth | -0.60 -566.67% | -0.70 | 0.10 | 14.75% |
| Q4 2022 Q2Q % growth | -0.66 | -0.67 | 0.01 | 1.96% |
| Q3 2022 Q2Q % growth | -0.72 | -1.01 | 0.29 | 28.70% |
| Q2 2022 Q2Q % growth | -0.14 | -0.10 | -0.04 | -37.25% |
| Q1 2022 Q2Q % growth | -0.09 | -0.09 | 0.00 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 3.178M 15.90% | 3.264M | -86K | -2.63% |
| Q3 2024 Q2Q % growth | 2.973M 20.85% | 3.06M | -87.03K | -2.84% |
| Q2 2024 Q2Q % growth | 2.891M 21.48% | 3.366M | -474.7K | -14.10% |
| Q1 2024 Q2Q % growth | 3.02M 46.60% | 3.162M | -142K | -4.49% |
| Q4 2023 Q2Q % growth | 2.742M 27.53% | 2.652M | 90K | 3.39% |
| Q3 2023 Q2Q % growth | 2.46M 27.46% | 2.448M | 12K | 0.49% |
| Q2 2023 Q2Q % growth | 2.38M 31.49% | 2.59M | -210K | -8.11% |
| Q1 2023 Q2Q % growth | 2.06M 17.05% | 2.232M | -172K | -7.71% |
| Q4 2022 Q2Q % growth | 2.15M 80.67% | 2.083M | 67K | 3.22% |
| Q3 2022 Q2Q % growth | 1.93M 93.00% | 2.144M | -214K | -9.98% |
| Q2 2022 Q2Q % growth | 1.81M 144.59% | 1.947M | -137K | -7.04% |
| Q1 2022 Q2Q % growth | 1.76M 291.11% | 1.632M | 128K | 7.84% |
| Q4 2021 Q2Q % growth | 1.19M 230.56% | % | ||
| Q3 2021 Q2Q % growth | 1M 163.16% | % | ||
| Q2 2021 Q2Q % growth | 740K 111.43% | % | ||
| Q1 2021 Q2Q % growth | 450K 36.36% | % | ||
| Q4 2020 Q2Q % growth | 360K 100.00% | % | ||
| Q3 2020 Q2Q % growth | 380K 216.67% | % | ||
| Q2 2020 Q2Q % growth | 350K 337.50% | % | ||
| Q1 2020 Q2Q % growth | 330K 1,550.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |